let’s make a mark
We are proud to collaborate with biopharma companies and leading healthcare systems to bring the next generation of liquid biopsy tests and more personalized treatment options to patients sooner.
It starts with the right patient. Our RNA-based liquid biopsy technology has the ability to transform the way patients are selected for more personalized and effective therapies that are developed for those in need. The promise of our platform is to bring innovative therapeutics to market quicker and accelerate drug development to improve patient outcomes.
Creating a better patient outcome. We continue to grow our partner ecosystem with academic institutions and healthcare systems. As we validate our findings and continue to develop the utility around tests, these partnerships have been instrumental to help us design a better test as well as find ways to integrate it into patient care workflows.
LET’S GET STARTED
talk to us about